Publicaciones en colaboración con investigadores/as de Novartis (Sweden) (4)

2020

  1. NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study

    JACC: Heart Failure, Vol. 8, Núm. 10, pp. 822-833

2019

  1. Effects of serelaxin in patients with acute heart failure

    New England Journal of Medicine, Vol. 381, Núm. 8, pp. 716-726

  2. Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study

    European Journal of Heart Failure, Vol. 21, Núm. 8, pp. 998-1007

2007

  1. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients

    Clinical Transplantation, Vol. 21, Núm. 1, pp. 18-23